Skip to content

Startup & venture capital news

Vitroscope raises USD 5m seed round

Separate grant funding supports live tissue drug research platform

By /

LinkedInX
Vitroscope: Vitroscope raises USD 5m seed round

Trondheim based Vitroscope announced a USD 5 million seed round on 3 November 2026, co led by Cerberus Ventures and YZR Capital. Arcas Ventures, Golden Egg Check, Devico Invest and several angels also participated. The company separately secured USD 2 million in non dilutive funding from the Research Council of Norway. Vitroscope develops perfusion systems that keep living human tissue under controlled flow, oxygen and temperature conditions for longer experiments. The equity funding will support commercial rollout of its vitro.alive benchtop platform and validation of vitro.scale, a higher throughput system planned for customer testing in 2027.

Keep reading

More Funding

All stories